☆ 4.7 Article

Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system

JOURNAL OF MEDICAL VIROLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cell Biology

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

Simone Lanini et al.

Summary: Safe and effective COVID-19 vaccines are crucial for ending the pandemic. A vaccine called GRAd-COV2, based on a gorilla adenovirus and expressing the spike protein of SARS-CoV-2, has been evaluated for safety and immunogenicity in healthy younger and older adults.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Letter Surgery

Will the next spillover pandemic be deadlier than the COVID-19?: A wake-up call

Om Prakash Choudhary et al.

INTERNATIONAL JOURNAL OF SURGERY (2022)

添加到收藏夹

Article Infectious Diseases

Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand

Kitikhun Udom et al.

Summary: A large-scale serological survey in Thailand during the early stages of the COVID-19 outbreaks found evidence of SARS-CoV-2 exposure in dogs and cats, despite all positive samples showing negative results for neutralizing antibodies.

TRANSBOUNDARY AND EMERGING DISEASES (2022)

添加到收藏夹

Article Immunology

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

Anh Duc Dang et al.

Summary: Affordable COVID-19 vaccines are necessary in low- and middle-income countries. An inactivated NDV-HXP-S vaccine expressing the spike protein of SARS-CoV-2 was tested in a phase 1/2 trial in Vietnam, showing acceptable safety and strong immunogenicity. The 3 μg dose performed the best 14 days after vaccination.

VACCINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

Punnee Pitisuttithum et al.

Summary: This study presents the phase 1 clinical trial results of the NDV-HXP-S vaccine, which demonstrated good safety profile and immunogenicity.

ECLINICALMEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies

Zhongfang Wang et al.

Summary: Understanding the decay of long-term SARS-CoV-2 neutralizing antibodies and how they protect against different variants is crucial for public vaccination plans. This study found that total neutralizing antibodies declined more slowly than other types of antibodies, and after 12 months, the neutralizing antibody levels were lower but could still neutralize different SARS-CoV-2 variants. The study also discovered the importance of virus-specific CD4(+) T cells and cTfh1 in maintaining long-term protective immunity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

添加到收藏夹

Article Immunology

A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners

Victor Neira et al.

Summary: This study described a household with two human adults and three cats infected with SARS-CoV-2. One female cat was asymptomatically infected, and the virus showed human-to-cat transmission.

EMERGING MICROBES & INFECTIONS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination

Bruno Pozzetto et al.

Summary: The study found that a heterologous vaccination regimen using ChAdOx1-S-nCoV-19 and BNT162b2 can provide better protection against SARS-CoV-2 infection with stronger neutralizing activity. This approach can activate memory B cells that recognize SARS-CoV-2, making it suitable for immunocompromised individuals.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

Weina Sun et al.

Summary: The rapid development of COVID-19 vaccines has been crucial in mitigating the spread of SARS-CoV-2, but equitable allocation of vaccines is necessary to limit global impact and the emergence of variants. A Newcastle disease virus-based COVID-19 vaccine candidate has been developed, inducing protective immunity in various animal models.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Immunology

Understanding the prevalence of SARS-CoV-2 (COVID-19) exposure in companion, captive, wild, and farmed animals

Hannah L. Murphy et al.

Summary: Several animal species, including pets like cats and dogs, have been shown to be susceptible to human coronaviruses such as SARS-CoV and SARS-CoV-2. Cats have been found to replicate the virus more efficiently than dogs and can transmit it through aerosols. Ongoing surveillance efforts are crucial to understand the impact of SARS-CoV-2 exposure in animals and the potential zoonotic transmission risks during the COVID-19 pandemic.

VIRULENCE (2021)

添加到收藏夹

Article Immunology

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats

Johnstone Tcheou et al.

Summary: Despite global vaccination efforts and relatively high rates in many regions, access to vaccines remains a challenge in low- and middle-income countries. Second generation vaccines that are affordable and induce strong immunity are needed to address this issue and combat the evolving SARS-CoV-2 virus.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection

Zhongfang Wang et al.

Summary: The study found virus-specific T-cell memory in COVID-19 patients and close contacts. Patients had stronger T cell responses compared to close contacts. Despite lacking detectable infection, close contacts were able to gain T-cell immunity against SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Microbiology

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Jesus Horacio Lara-Puente et al.

Summary: The study tested a second-generation SARS-CoV-2 vaccine that can be administered intranasally, showing both safety and high immunogenicity in a pig model. The vaccine can induce immune responses to variants of the virus, whether administered intranasally or intramuscularly.

MBIO (2021)

添加到收藏夹

Article Microbiology

SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence

Sushma Boppana et al.

Summary: This study examined cTfh responses to three major structural proteins of SARS-CoV-2 in COVID-19 recovered individuals, finding that cTfh frequencies correlate with neutralizing antibody responses and cTfh responses may be delayed post infection.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Immunology

Antibodies to SARS-CoV-2 in dogs and cats, USA

Subarna Barua et al.

Summary: A serosurvey on dogs and cats in the U.S. revealed some positive samples for SARS-CoV-2, but overall supported the current position that pets do not play a significant role in the spread of the virus to humans.

EMERGING MICROBES & INFECTIONS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Bezawit A. Woldemeskel et al.

Summary: Recent studies have shown that T cells can cross-recognize spike proteins of SARS-CoV-2 and common cold coronaviruses. Vaccination with SARS-CoV-2 mRNA vaccines results in broad T cell responses to the virus's spike protein, including potential recognition of variant spike proteins. Additionally, post-vaccination, there is an observed increase in CD4(+) T cell responses to certain common cold coronaviruses.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Bas B. Oude Munnink et al.

Summary: Animal experiments have shown that various animals can be infected by SARS-CoV-2, with evidence of animal-to-human transmission within mink farms. Investigation into mink farm outbreaks revealed that the virus was initially introduced by humans and has since evolved, causing transmission between mink farms. Despite enhanced biosecurity measures and culling, transmission occurred between farms in three large clusters with unknown modes of transmission, resulting in a high percentage of infections among mink farm residents and employees.

SCIENCE (2021)

添加到收藏夹

Editorial Material Microbiology

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Aiping Wu et al.

CELL HOST & MICROBE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Infection of dogs with SARS-CoV-2

Thomas H. C. Sit et al.

NATURE (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

添加到收藏夹

Article Environmental Sciences

Aerosol transmission of SARS-CoV-2? Evidence, prevention and control

Song Tang et al.

ENVIRONMENT INTERNATIONAL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

CELL (2020)

添加到收藏夹

Article Immunology

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Emilie Seydoux et al.

IMMUNITY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett et al.

NATURE (2020)

添加到收藏夹

Article Cell Biology

An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Jesse H. Erasmus et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Review Microbiology

Coronaviruses in cats and other companion animals: Where does SARS-CoV2/COVID-19 fit?

Alison E. Stout et al.

VETERINARY MICROBIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain

Joaquim Segales et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Shipo Wu et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Review Veterinary Sciences

Natural Infection by SARS-CoV-2 in Companion Animals: A Review of Case Reports and Current Evidence of Their Role in the Epidemiology of COVID-19

Helio Autran de Morais et al.

FRONTIERS IN VETERINARY SCIENCE (2020)

添加到收藏夹

Article Veterinary Sciences

SARS-COV-2 INFECTION AND LONGITUDINAL FECAL SCREENING IN MALAYAN TIGERS (PANTHERA TIGRIS JACKSONI), AMUR TIGERS (PANTHERA TIGRIS ALTAICA), AND AFRICAN LIONS (PANTHERA LEO KRUGERI) AT THE BRONX ZOO, NEW YORK, USA

Susan L. Bartlett et al.

JOURNAL OF ZOO AND WILDLIFE MEDICINE (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Tfh Cells in Health and Immunity: Potential Targets for Systems Biology Approaches to Vaccination

Hannah Law et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Microbiology

Origin and evolution of pathogenic coronaviruses

Jie Cui et al.

NATURE REVIEWS MICROBIOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular Evolution of Human Coronavirus Genomes

Diego Forni et al.

TRENDS IN MICROBIOLOGY (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

Shuo Su et al.

TRENDS IN MICROBIOLOGY (2016)

添加到收藏夹

Review Virology

Newcastle disease virus: Current status and our understanding

Ketan Ganar et al.

VIRUS RESEARCH (2014)

添加到收藏夹

Review Immunology

The who, how and where of antigen presentation to B cells

Facundo D. Batista et al.

NATURE REVIEWS IMMUNOLOGY (2009)

添加到收藏夹

Article Virology

Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone

Carlos Estevez et al.

VIRUS RESEARCH (2007)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Paramyxovirus mRNA editing, the 'rule of six' and error catastrophe: a hypothesis

D Kolakofsky et al.

JOURNAL OF GENERAL VIROLOGY (2005)

添加到收藏夹

Review Veterinary Sciences

Newcastle disease and other avian paramyxoviruses

DJ Alexander

REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.